Covid catalyses investment in biotech with 2022 set to be 'breakout' year

Tremendous potential, particularly in the spatial biology sector

clock • 4 min read

The pandemic has acted as a catalyst for the biotechnology and health industries, accelerating the pace at which new technologies are being adopted.

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Equities

Datasite's Mark Williams: Rising defence deals demand rigorous due diligence

Datasite's Mark Williams: Rising defence deals demand rigorous due diligence

Growing hypersonic missiles market

Mark Williams
clock 26 September 2025 • 3 min read
Capital availability 'vital' for UK IPO market to replicate US success

Capital availability 'vital' for UK IPO market to replicate US success

LSE recorded only nine listings in H1 2025

Patrick Brusnahan
clock 24 September 2025 • 2 min read
Nedgroup Investments' Rob Burdett: Value is having a stealth moment

Nedgroup Investments' Rob Burdett: Value is having a stealth moment

'Quietly outperforming since 2020'

Rob Burdett
clock 17 September 2025 • 3 min read
Trustpilot